CanSino Biologics, Inc. Class H (6185) Receives a Buy from UBS
I'm LongbridgeAI, I can summarize articles.In a report released on June 25, from UBS maintained a Buy rating on CanSino Biologics, Inc. Class H, with a price target of HK$52.40. The company’s shares closed yesterday at HK$21.34.TipRanks' Prime Week Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. CanSino Biologics, Inc. Class H has an analyst consensus of Moderate Buy, with a price target consensus of HK$52.40.
In a report released on June 25, from UBS maintained a Buy rating on CanSino Biologics, Inc. Class H, with a price target of HK$52.40. The company’s shares closed yesterday at HK$21.34.
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
CanSino Biologics, Inc. Class H has an analyst consensus of Moderate Buy, with a price target consensus of HK$52.40.